Syneos taking Enteris’s endometriosis treatment to Ph IIa
Enteris BioPharma has completed recruitment and initial dosing of all subjects for an additional treatment arm of its Phase IIa clinical trial, which is being conducted by Syneos.
Enteris BioPharma has completed recruitment and initial dosing of all subjects for an additional treatment arm of its Phase IIa clinical trial, which is being conducted by Syneos.
In a deal worth $640m, LabCorp has sold its Covance Food Solutions business to Eurofins Scientific to focus on its "core lab business."
The R&D facility will help clients advance pharmaceutical ingredients from preclinical to commercial stage, says the contract development and manufacturing organisation.